Alzheimer's Disease Insurance Claim Denied? How to Appeal

A diagnosis of Alzheimer's disease brings enough challenges without the added burden of fighting your insurance company. Yet denials for cognitive testing, memory care, disease-modifying medications, and long-term care services are distressingly common. Alzheimer's disease claims use ICD-10 codes G30.0 (early onset), G30.1 (late onset), G30.8 (other), and G30.9 (unspecified). Under the ACA Essential Health Benefits framework, diagnostic services, physician visits, and medication management are covered services. The American Academy of Neurology (AAN) Practice Guidelines affirm that cognitive assessments including PET imaging are medically appropriate for diagnosis and treatment planning, and Medicare's coverage of lecanemab (Leqembi) and donanemab establishes federal recognition that disease-modifying Alzheimer's treatment is medically necessary. If your insurer has rejected a claim, you can win with the right evidence and legal arguments.

Why Insurers Deny Alzheimer's Disease Claims

Insurance companies deny Alzheimer's claims for several recurring reasons, each requiring a different response:

• "Not medically necessary" — The most frequent denial language; insurers may argue memory care facilities or ongoing cognitive assessments are custodial rather than medical, a characterization that clinical guidelines and court decisions have consistently rejected
• Custodial care exclusion — Insurers draw a line between skilled nursing care (covered) and custodial care (help with daily activities); the key argument is that Alzheimer's care involves medical supervision, medication management, behavioral intervention, and safety protocols that constitute skilled care
• Cognitive testing frequency denied — Insurers claim assessment frequency is excessive or that results will not change treatment; regular neuropsychological testing is essential for tracking disease progression and adjusting medications per Alzheimer's Association guidelines
• Long-term care policy disputes — Disputes arise over whether the policyholder has met the benefit trigger requirements, typically inability to perform at least two ADLs or meeting a specific cognitive impairment standard
• New disease-modifying drug denials — Lecanemab (Leqembi) and donanemab received FDA approval for early Alzheimer's disease; some commercial payers deny these drugs as "experimental" despite FDA approval and CMS coverage determinations

How to Appeal an Alzheimer's Disease Insurance Denial

Step 1: Get the Denial in Writing and Identify the Specific Denial Type

If you have not received a detailed written denial, contact the insurer and request one — it must state the specific reason, the policy provision relied on, and instructions for filing an appeal. Then identify which denial type applies: custodial care exclusion, not medically necessary, LTC benefit trigger not met, experimental drug, or cognitive testing frequency. Different denial types require different strategies, and a single generic letter cannot address all of them.

Step 2: Reframe Memory Care as Skilled Medical Care

For custodial care exclusion denials, your appeal must establish that Alzheimer's memory care constitutes skilled medical services including complex polypharmacy management requiring nursing oversight, behavioral health interventions for agitation, wandering, and psychosis, medical complication monitoring (aspiration, pressure injuries, infections), structured evidence-based dementia care programs with clinical outcomes data, and 24-hour safety supervision for patients with documented risk behaviors. Cite the Alzheimer's Association Care Practice Guidelines and AAN Practice Parameters directly.

Step 3: Document Functional Impairment Formally for LTC Benefit Triggers

Obtain formal ADL assessments from your neurologist, geriatrician, or licensed social worker. Document impairment in the number of ADLs required by your policy. Include specific examples of what the patient can no longer do independently, CDR (Clinical Dementia Rating) or FAST (Functional Assessment Staging Test) scores documenting disease stage, and MMSE or MoCA results.

Step 4: Obtain a Specialist Medical Necessity Letter Referencing Guidelines

Request a detailed letter from your neurologist or geriatrician addressing the Alzheimer's diagnosis, stage, and ICD-10 code, the clinical necessity of the specific denied service or medication, references to Alzheimer's Association Care Guidelines and AAN Practice Parameters, why the insurer's "custodial care" or "not medically necessary" characterization is clinically incorrect, and medical risks if the denied care is not provided.

Step 5: Cite FDA Approval and Medicare Coverage for Disease-Modifying Drug Denials

For commercial payers denying lecanemab (Leqembi) or donanemab as "experimental," cite the specific FDA approval dates and CMS coverage decisions directly. Dementia care management programs have demonstrated measurable outcomes including reduced hospitalizations and emergency room visits — supporting the argument that structured memory care is medically beneficial and not purely custodial. Medicare's coverage decision creates federal precedent that these treatments are medically necessary.

Step 6: File the Internal Appeal, Then Request External Independent Review: Complete Guide" class="auto-link">External Review if Denied

Submit your complete appeal package to the insurer's appeals department within the deadline (typically 180 days for commercial plans). For urgent care situations, request expedited review — the insurer must respond within 72 hours. If the internal appeal fails, request external review by an IROs) Explained" class="auto-link">Independent Review Organization (IRO). External review is free under the ACA, the IRO's decision is binding, and external reviewers frequently reverse Alzheimer's care denials supported by specialist documentation and clinical guidelines.

What to Include in Your Alzheimer's Appeal

• Written denial letter with specific reason and policy provision cited, plus neurologist or geriatrician's formal diagnosis letter with ICD-10 code
• Neuropsychological assessment results (MMSE, MoCA, or full battery) and CDR or FAST score documenting disease stage
• ADL assessment results documenting functional impairment, memory care facility assessment and care plan if applicable, and documentation of safety risks
• Clinical guideline citations from Alzheimer's Association and AAN, plus FDA approval and Medicare coverage documentation for disease-modifying drugs denied as experimental

Fight Back With ClaimBack

Alzheimer's disease insurance appeals require reframing custodial care exclusions, documenting functional impairment with formal assessments, and citing AAN and Alzheimer's Association guidelines alongside CMS precedent. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal